- Home
- PRQR vs WALD Comparison
PRQR vs WALD Comparison
Compare PRQR & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRQR | WALD |
|---|---|---|
| Founded | 2012 | 1988 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 250.7M | 246.7M |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PRQR | WALD |
|---|---|---|
| Price | $2.10 | $1.47 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $8.14 | $4.88 |
| AVG Volume (30 Days) | ★ 566.5K | 93.9K |
| Earning Date | 11-06-2025 | 11-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $18,859,556.00 | ★ $274,560,000.00 |
| Revenue This Year | N/A | $4.61 |
| Revenue Next Year | $19.56 | $11.22 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 14.22 |
| 52 Week Low | $1.07 | $1.48 |
| 52 Week High | $3.10 | $4.10 |
Technical Indicators
Market Signals| Indicator | PRQR | WALD |
|---|---|---|
| Relative Strength Index (RSI) | 46.93 | 26.13 |
| Support Level | $1.92 | $1.84 |
| Resistance Level | $2.28 | $1.64 |
| Average True Range (ATR) | 0.15 | 0.13 |
| MACD | 0.00 | -0.05 |
| Stochastic Oscillator | 45.03 | 0.00 |
Price Performance
Historical ComparisonAbout PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.